SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014)
- 28 August 2020
- journal article
- correction
- Published by Elsevier BV in Cancer Letters
- Vol. 486, 71-72
- https://doi.org/10.1016/j.canlet.2020.05.010
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: